First drug for Dupuytren's contracture approved by US FDA
This article was originally published in Scrip
Executive Summary
Auxilium Pharmaceuticals' novel therapy Xiaflex (collagenase clostridium histolyticum) has become the first US-approved drug to treat a potentially debilitating hand condition known as Dupuytren's contracture. The launch of Xiaflex is planned for late March.